On 12 February 2025 [Opinion of the Committee for Veterinary Medicinal Products of 12 February 2025 on the establishment of maximum residue limits (EMA/CVMP/27344/2025).], the Agency, based on the opinion of the Committee for Veterinary Medicinal Products, recommended the establishment of MRLs for fluralaner use in Salmonidae, applicable to muscle and skin in natural proportions. The Agency concluded that the extension by extrapolation of the MRLs for fluralaner to all fin fish is appropriate.
Recital 6, Regulation (EU) 2025/1908
In forcesince 24 Sep 2025